Covered recipient · General Payments record
AYOBAMI NIFEMI ODUWOLE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021
$92,225.52
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $92,225.52 | 53 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $92,225.52 | 53 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2021 | $92,225.52 | 53 |
Payment records · PY2021 (53)
Sorted by paying entity, then date · as published by CMS
Program year 2021
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $1,137.84 | 01/01/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404543 | CMS |
| AbbVie Inc. | $1,137.84 | 01/04/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404549 | CMS |
| AbbVie Inc. | $1,896.40 | 01/13/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404555 | CMS |
| AbbVie Inc. | $1,896.40 | 01/20/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404561 | CMS |
| AbbVie Inc. | $1,517.12 | 01/25/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404567 | CMS |
| AbbVie Inc. | $1,896.40 | 02/01/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404573 | CMS |
| AbbVie Inc. | $1,896.40 | 02/10/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404579 | CMS |
| AbbVie Inc. | $1,896.40 | 02/21/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404585 | CMS |
| AbbVie Inc. | $1,896.40 | 02/21/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404591 | CMS |
| AbbVie Inc. | $1,896.40 | 03/01/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404597 | CMS |
| AbbVie Inc. | $1,896.40 | 03/07/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404603 | CMS |
| AbbVie Inc. | $1,896.40 | 03/15/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404609 | CMS |
| AbbVie Inc. | $1,896.40 | 03/28/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404615 | CMS |
| AbbVie Inc. | $1,896.40 | 03/28/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404621 | CMS |
| AbbVie Inc. | $1,896.40 | 04/05/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404629 | CMS |
| AbbVie Inc. | $1,896.40 | 04/13/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404635 | CMS |
| AbbVie Inc. | $1,517.12 | 04/18/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404641 | CMS |
| AbbVie Inc. | $1,896.40 | 04/24/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404647 | CMS |
| AbbVie Inc. | $1,896.40 | 05/03/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404653 | CMS |
| AbbVie Inc. | $1,896.40 | 05/10/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404659 | CMS |
| AbbVie Inc. | $1,896.40 | 05/17/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404665 | CMS |
| AbbVie Inc. | $1,517.12 | 05/24/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404671 | CMS |
| AbbVie Inc. | $1,896.40 | 06/01/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404677 | CMS |
| AbbVie Inc. | $1,517.12 | 06/07/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404683 | CMS |
| AbbVie Inc. | $1,896.40 | 06/15/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404689 | CMS |
| AbbVie Inc. | $1,659.35 | 06/21/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404695 | CMS |
| AbbVie Inc. | $1,896.40 | 07/05/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404701 | CMS |
| AbbVie Inc. | $1,517.12 | 07/06/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404707 | CMS |
| AbbVie Inc. | $1,517.12 | 07/12/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404713 | CMS |
| AbbVie Inc. | $1,896.40 | 07/19/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404719 | CMS |
| AbbVie Inc. | $1,745.29 | 07/26/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404725 | CMS |
| AbbVie Inc. | $1,886.80 | 08/02/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404731 | CMS |
| AbbVie Inc. | $1,886.80 | 08/09/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404737 | CMS |
| AbbVie Inc. | $1,886.80 | 08/16/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404743 | CMS |
| AbbVie Inc. | $1,886.80 | 08/24/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404749 | CMS |
| AbbVie Inc. | $377.36 | 09/07/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404755 | CMS |
| AbbVie Inc. | $1,886.80 | 09/21/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404761 | CMS |
| AbbVie Inc. | $1,509.44 | 09/21/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404767 | CMS |
| AbbVie Inc. | $1,886.80 | 09/21/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404773 | CMS |
| AbbVie Inc. | $1,509.44 | 10/04/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404779 | CMS |
| AbbVie Inc. | $1,886.80 | 10/12/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404785 | CMS |
| AbbVie Inc. | $1,886.80 | 10/15/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404793 | CMS |
| AbbVie Inc. | $1,886.80 | 10/18/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404799 | CMS |
| AbbVie Inc. | $1,886.80 | 10/25/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404805 | CMS |
| AbbVie Inc. | $1,886.80 | 11/01/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404811 | CMS |
| AbbVie Inc. | $1,886.80 | 11/08/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404817 | CMS |
| AbbVie Inc. | $1,886.80 | 11/15/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404823 | CMS |
| AbbVie Inc. | $1,509.44 | 11/22/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404829 | CMS |
| AbbVie Inc. | $1,132.08 | 11/29/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404835 | CMS |
| AbbVie Inc. | $1,768.88 | 12/06/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404841 | CMS |
| AbbVie Inc. | $1,886.80 | 12/13/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404847 | CMS |
| AbbVie Inc. | $1,886.80 | 12/20/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404853 | CMS |
| AbbVie Inc. | $1,509.44 | 12/28/2021 | Consulting Fee | Undisputed | 01/23/2026 | 795404859 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021
- Source files
- Dataset page · Bulk file · PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.